[1]
“THROMBOEMBOLIC RISKS ASSOCIATED WITH THE USE OF HORMONAL CONTRACEPTIVES: INTEGRATIVE REVIEW”, REMUNOM, vol. 21, no. 02, pp. 1–19, Dec. 2025, doi: 10.61164/tqyvzh73.